Friederich HC, Vogelsberg H, Neiss A. Evaluation of internally effective venous drugs [translated from German].
Z Hautkr.
1978;53:369 - 374.
Neiss A, Bohm C. Demonstration of the effectiveness of the horse-chestnut-seed extract in the varicose syndrome complex [translated from German].
MMW Munch Med Wochenschr. 1976;118:213 - 216.
Bisler H, Pfeifer R, Kluken N, et al. Effects of horse-chestnut seed extract on transcapillary filtration in chronic venous insufficiency [translated from German].
Dtsch Med Wochenschr.
1986,111:1321 - 1329.
Lohr E, Garanin G, Jesau P, et al. Anti-edemic therapy in chronic venous insufficiency with tendency to formation of edema [translated from German].
Munch Med Wochenschr
1986;128:579 - 581.
Rudofsky G, Neiss A, Otto K, et al. Antiedematous effects and clinical effectiveness of horse chestnut seed extract in double blind studies [translated from German].
Phlebologie und Proktologie.
1986;15:47 - 54.
Steiner M, Hillemanns HG. Investigation of the anti-edemic efficacy of Venostatin [translated from German].
Munch Med Wochenschr.
1986;128:551 - 552.
Alter H. Medication therapy for varicosis [translated from German].
Z Allgemeinmed.
1973;49:1301 - 1304.
Diehm C, Trampisch HJ, Lange S, et al. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency.
Lancet. 1996;347:292 - 294.
Pittler MH and Ernst E. Horse-chestnut seed extract for chronic venous insufficiency. A criteria-based systematic review.
Arch Dermatol.
1998;134:1356 - 1360.
Neiss A, Bohm C. Demonstration of the effectiveness of the horse-chestnut-seed extract in the varicose syndrome complex [translated from German].
MMW Munch Med Wochenschr. 1976;118:213 - 216.
Lohr E, Garanin G, Jesau P, et al. Anti-edemic therapy in chronic venous insufficiency with tendency to formation of edema [translated from German].
Munch Med Wochenschr.
1986;128:579 - 581.
Diehm C, Trampisch HJ, Lange S, et al. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency.
Lancet. 1996;347:292 - 294.
Kreysel HW, Nissen HP, Enghofer E. A possible role of lysosomal enzymes in the pathogenesis of varicosis and the reduction in their serum activity by Venostasin.
Vasa.
1983;12:377 - 382.
Bougelet C, Roland IH, Ninane N, et al. Effect of aescine on hypoxia-induced neutrophil adherence to umbilical vein endothelium.
Eur J Pharmacol. 1998;345:89 - 95.
Unkauf M, Rehn D, Klinger J, et al. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.
Arzneimittelforschung.
1996;46:478 - 482.
MacLennan WJ, Wilson J, Rattenhuber V, et al. Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability.
Gerontology.
1994;40:45 - 52.
Rehn D, Brunnauer H, Diebschlag W, et al. Investigation of the therapeutic equivalence of different galenical preparations of O-(beta-hydroxyethyl)-rutosides following multiple dose peroral administration.
Arzneimittelforschung.
1996;46:488 - 492.
Rehn D, Unkauf M, Klein P, et al. Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency.
Arzneimittelforschung.
1996;46:483 - 487.
Balmer A, Limoni C. Clinical, placebo-controlled double-blind study of venoruton in the treatment of chronic venous insufficiency. Importance of the selection of patients [in German; English abstract].
Vasa.
1980;9:76 - 82.
Bergqvist D, Hallbook, Lindblad B, et al. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency.
Vasa.
1981;10:253 - 260.
Anderson JH, Geraghty JG, Wilson YT, et al. Paroven and graduated compression hosiery for superficial venous insufficiency.
Phlebology.
1990;5:271 - 276.
van Cauwenberge H. Double blind study of the efficacy of O(beta-hydroxyethyl)-rutosides in the treatment of venous conditions [in French].
Med Hyg (Geneve). 1978;36:4175 - 4177.
de Jongste AB, Jonker JJ, Huisman MV, et al. A double blind three center clinical trial on the short-term efficacy of O-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome.
Thromb Haemost.
1989;62:826 - 829.
Prerovsky I, Roztocil K, Hlavova A, et al. The effect of hydroxyethylrutosides after acute and chronic oral adminstration in patients with venous diseases. A double-blind study.
Angiologica.
1972;9:408 - 414.
Cappelli R, Pecchi S, Oberhauser V, et al. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
IntJ Clin Pharmacol Res.
1987;7:291 - 299.
Boisseau MR, Taccoen A, Garreau C, et al. Fibrinolysis and hemorheology in chronic venous insufficiency: a double blind study of troxerutin efficiency.
J Cardiovasc Surg (Torino).
1995;36:369 - 374.
Rehn D, Golden G, Nocker W, et al. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency.
Arzneimittelforschung.
1993;43:1060 - 1063.
Ihme N, Kiesewetter H, Jung F, et al. Leg oedema protection from a buckwheat herb tea in patients with chronic venous insufficiency: a single-centre, randomised, double-blind, placebo-controlled clinical trial.
Eur J Clin Pharmacol.
1996;50:443 - 447.
Koscielny J, Radtke H, Hoffmann KH, et al. Fagorutin buckwheat herb tea in chronic venous insufficiency [translated from German].
Z Phytother. 1996;17:147 - 150, 153 - 156, 159.
Tsouderos Y. Venous tone: are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg.
Z Kardiol.
1991;80(suppl 7):95 - 101.
Amato C. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
Angiology.
1994;45:531 - 536.
Cospite M, Dominici A. Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form.
Int Angiol.
1989;8(suppl 4):61 - 65.
Dominguez C, Brautigam I, Gonzalez E, et al. Therapeutic effect of hidrosmin on chronic venous insufficiency if lower limbs.
Curr Med Res Opin.
1992;12:623 - 630.
Fermoso J, Legido AG, del Pino J, et al. Therapeutic value of hidrosmin in the treatment of venous disorders of the lower limbs.
Curr Ther Res.
1992;52:124 - 134.
Meyer OC. Safety and security of Daflon 500 mg in venous insufficiency and in hemorrhoidal disease.
Angiology.
1994;45:579 - 584.
Schwitters B, Masquelier J.
OPC in Practice: Bioflavanols and Their Applications. Rome, Italy: Alfa Omega; 1993.
Masquelier J, Dumon MC, Dumas J. Stabilization of collagen by procyanidolic oligomers [in French; English abstract].
Acta Ther. 1981;7:101 - 105.
Masquelier J. Procyanidolic oligomers (Leucocyanidins) [translated from French].
Parfums Cosmetiques Aromes. 1990;95:89 - 97.
Tixier JM, Godeau G, Robert AM, et al. Evidence by in vivo and in vitro studies that binding of pycnogenols to elastin affects its rate of degradation by elastases.
Biochem Pharmacol. 1984;33:3933 - 3939.
Bombardelli E, Morazzoni P.
Vitis vinifera
L.
Fitoterapia. 1995;66:291 - 317.
Henriet JP.
Exemplary study for a phlebotropic substance, the EIVE Study
[translated from French]. Fairfield, Conn: Primary Source; not dated.
Delacroix P. Double-blind study of Endotelon® in chronic venous insufficiency [translated from French].
La Revue de Medecine. 1981;22:1793 - 1802.
Thebaut JF, Thebaut P, Vin F. Study of Endotelon® in functional manifestations of peripheral venous insufficiency [translated from French].
Gaz Med.
1985;92:96 - 100.
Arcangeli P. Pycnogenol in chronic venous insufficiency.
Fitoterapia.
2000;71:236 - 244.
Petrassi C, Mastromarino A, Spartera C. Pycnogenol in chronic venous insufficiency.
Phytomedicine. 2000;7:383 - 388.
Thebaut JF, Thebaut P, Vin F. Study of Endotelon® in functional manifestations of peripheral venous insufficiency [translated from French].
Gaz Med.
1985;92:96 - 100.
Arcangeli P. Pycnogenol in chronic venous insufficiency.
Fitoterapia.
2000;71:236 - 244.
Petrassi C, Mastromarino A, Spartera C. Pycnogenol in chronic venous insufficiency.
Phytomedicine. 2000;7:383 - 388.
Henriet JP.
Exemplary study for a phlebotropic substance, the EIVE Study
[translated from French]. Fairfield, Conn: Primary Source; not dated.
Kartnig T. Clinical applications of
Centella asiatica
(L.).
Herbs Spices Med Plants. 1988;3:146 - 173.
Castellani C, Marai A, Vacchi P. The
Centella asiatica
[in Italian; English abstract].
Boll Chim Farm. 1981;120:570 - 605.
Belcaro GV, Grimaldi R, Guidi G. Improvement of capillary permeability in patients with venous hypertension after treatment with TTFCA.
Angiology.
1990;41:533 - 540.
Belcaro GV, Rulo A, Grimaldi R. Capillary filtration and ankle edema in patients with venous hypertension treated with TTFCA.
Angiology. 1990;41:12 - 18.
Cesarone MR, Laurora G, DeSactis MT, et al. The microcirculatory activity of
Centella asiatica
in venous insufficiency: a double-blind study [translated from Italian].
Minerva Cardioangiol. 1994;42:299 - 304.
Pointel JP, Boccalon H, Cloarec M, et al. Titrated extract of
Centella asiatica
(TECA) in the treatment of venous insufficiency of the lower limbs.
Angiology. 1987;38:46 - 50.
Cesarone MR, Laurora G, DeSactis MT, et al. Activity of
Centella asiatica
in venous insufficiency [in Italian; English abstract].
Minerva Cardioangiol. 1992;40:137 - 143.
Kiesewetter H, Koscielny J, Kalus U, et al. Efficacy of orally administered extract of red vine leaf AS 195
(folia vitis viniferae)
in chronic venous insufficiency (stages I - II).
Arzneimittelforschung.
2000;50:109 - 117.
Cappelli R, Nicora M, Di Perri T. Use of extract of Ruscus aculeatus in venous disease in the lower limbs.
Drugs Exp Clin Res. 1988;14:277 - 283.
Lucker P, Jost V, Wolna P, et al. Efficacy and safety of ruscus extract compared to placebo in patients suffering from chronic venous insufficiency [abstract].
Phytomedicine. 2000;7(suppl 2):P-155.
Rudofsky G, Diehm C, Gruss JD, et al. Chronic venous insufficiency. Treatment with
Ruscus
extract and trimethylhesperidin chalcone [in German; English abstract].
MMW Munch Med Wochenschr. 1990;132:205 - 210.
Weindorf N, Schultz-Ehrenburg U. Controlled study of increasing venous tone in primary varicose veins by oral administration of
Ruscus aculeatus
and trimethylhespiridinchalcone [in German; English abstract].
Z Hautkr. 1987;62:28 - 30, 35 - 38.
Petruzzellis V, Velon A. Therapeutic action of oral doses of mesoglycan in the pharmacological treatment of varicose syndrome and its complications [in Italian; English abstract].
Minerva Med. 1985;76:543 - 548.
Sangrigoli V, Carra G, Lazzara N, et al. Mesoglycan in acute and chronic venous insufficiency of the legs [in Italian; English abstract].
Clin Ther. 1989;129:207 - 209.
Oddone G, Fiscella GF, De Franceschi T. Assessment of the effects of oral mesoglycan sulphate in patients with chronic venous pathology of the lower extremities [in Italian; English abstract].
Gazz Med Ital. 1987;146:111 - 114.
Arosio E, Ferrari G, Santoro L, et al. A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers.
Eur J Vasc Endovasc Surg.
2001;22:365 - 372.
Arosio E, Ferrari G, Santoro L, et al. A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers.
Eur J Vasc Endovasc Surg.
2001;22:365 - 372.
Laurent R, Gilly R, Frileux C. Clinical evaluation of a venotropic drug in man. Example of Daflon 500 mg.
Int Angiol.
1988;7:39-43.
Danielsson G, Jungbeck C, Peterson K, et al. A randomised, controlled trial of micronised purified flavonoid fraction vs placebo in patients with chronic venous disease.
Eur J Vasc Endovasc Surg.
2002;23:73 - 76.
Vanscheidt W, Jost V, Wolna P, et al. Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency.
Arzneimittelforschung. 2002;52(4):243-250.
Koch R. Comparative study of Venostasin and Pycnogenol in chronic venous insufficiency.
Phytother Res.
2002;16 Suppl 1:S1-5.
Petruzzellis V, Troccoli T, Candiani C, et al. Oxerutins (Venoruton): efficacy in chronic venous insufficiency - a double-blind, randomized, controlled study.
Angiology. 2002;53:257 - 263.
Incandela L, Belcaro G, Renton S, et al. HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in Venous Hypertensive Microangiopathy: A Prospective, Placebo-Controlled, Randomized Trial.
J Cardiovasc Pharmacol Ther. 2002;7(Suppl 1):S7 - S10.
Último revisado julio 2012 por EBSCO CAM Review Board
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.
Copyright © EBSCO Publishing. All rights reserved.